BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jun 21, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BG-12: Phase II started

Biogen Idec began the open-label, U.S. Phase II EXPLORE trial to evaluate 240 mg BG-12 given thrice daily in 100 patients receiving a...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >